These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 8969678)
1. NSAIDs and the gastrointestinal mucosa. Wolfe MM Hosp Pract (1995); 1996 Dec; 31(12):37-44, 47-8. PubMed ID: 8969678 [TBL] [Abstract][Full Text] [Related]
2. [Prostaglandins and damage to the gastric mucosa]. Varró V Orv Hetil; 1991 Jul; 132(27):1461-7. PubMed ID: 1683479 [TBL] [Abstract][Full Text] [Related]
3. [Prophylaxis and therapy of gastropathy caused by non-steroidal anti-inflammatory drugs]. László A Orv Hetil; 2002 Jul; 143(27):1643-8. PubMed ID: 12180001 [TBL] [Abstract][Full Text] [Related]
4. Treatment and prevention of nonsteroidal anti-inflammatory drug induced gastrointestinal mucosal injury. Agrawal NM; Dajani EZ Int J Clin Pharmacol Res; 1989; 9(6):347-57. PubMed ID: 2576801 [TBL] [Abstract][Full Text] [Related]
6. Prostaglandins and gastric ulcers: from seminal vesicle to misoprostol (Cytotec). Feldman M Am J Med Sci; 1990 Aug; 300(2):116-32. PubMed ID: 1976294 [TBL] [Abstract][Full Text] [Related]
7. Histamine H2-receptor antagonists in peptic ulcer disease. Evidence for a prophylactic use. Nash J; Lambert L; Deakin M Drugs; 1994 Jun; 47(6):862-71. PubMed ID: 7521828 [TBL] [Abstract][Full Text] [Related]
8. [The availability of prostaglandin derivatives in a treatment and prevention for gastrointestinal mucosal injury]. Harada S; Takeuchi T; Edogawa S; Ota K; Kojima Y; Higuchi K Nihon Rinsho; 2015 Jul; 73(7):1153-8. PubMed ID: 26165072 [TBL] [Abstract][Full Text] [Related]
10. NSAID-induced peptic ulcer disease: a critical review of pathogenesis and management. Scheiman JM Dig Dis; 1994; 12(4):210-22. PubMed ID: 7851000 [TBL] [Abstract][Full Text] [Related]
11. Gastric cytoprotection. What does it really mean for the prescriber? Guslandi M Drugs; 1991 Apr; 41(4):507-13. PubMed ID: 1711956 [No Abstract] [Full Text] [Related]
12. Options in the treatment and prevention of NSAID-induced gastroduodenal mucosal damage. Agrawal NM; Dajani EZ J Rheumatol Suppl; 1990 Feb; 20():7-11. PubMed ID: 1969964 [TBL] [Abstract][Full Text] [Related]
15. Is NSAIDs-related gastrointestinal damage preventable? Gargallo CJ; Lanas A J Dig Dis; 2013 Feb; 14(2):55-61. PubMed ID: 23216831 [TBL] [Abstract][Full Text] [Related]
16. Prostaglandins in peptic ulceration. Fenn GC Br J Hosp Med; 1992 Dec 2-1993 Jan 5; 48(11):776. PubMed ID: 1361396 [No Abstract] [Full Text] [Related]
17. Prostaglandins: viable therapy in gastric ulceration. Janusz AG; Janusz AJ S D J Med; 1993 Feb; 46(2):45-7. PubMed ID: 8441926 [TBL] [Abstract][Full Text] [Related]
18. Non-steroidal anti-inflammatory drug gastropathy: causes and treatment. Hawkey CJ Scand J Gastroenterol Suppl; 1996; 220():124-7. PubMed ID: 8898449 [TBL] [Abstract][Full Text] [Related]
19. Treatment of nonsteroidal anti-inflammatory drug-associated gastric and duodenal damage. Efficacy of antisecretory drugs and mucosal protective compounds. Pipkin G; Mills JG Dig Dis; 1995 Jan; 13 Suppl 1():75-88. PubMed ID: 7697904 [TBL] [Abstract][Full Text] [Related]
20. A clinical approach to management of patients with non-steroidal anti-inflammatory gastropathy. Yeomans ND Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S89-92. PubMed ID: 10379475 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]